KPA urged government not to discuss revision to pharmaceutical affairs law with medical community.

Published: 2000-10-24 11:56:00

Updated: 2000-10-24 11:56:00

The KPA, a pharmacist lobbying organization, clearly stated on Oct. 20 that they would never accept any attempt of revising the pharmaceutical affairs law containing many contradicted issues to their interests including elimination of the substitutive dispensing only made between the government a...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK